Optune: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

29 March 2024

  • curprev 07:1007:10, 29 March 2024‎ Lazy talk contribs‎ 1,930 bytes +106‎ No edit summary
  • curprev 07:0507:05, 29 March 2024‎ Lazy talk contribs‎ 1,824 bytes +1,824‎ Created page with "{{TreatmentInfo |drug_name=Optune (Optune Gio® for newer version) |FDA_approval=Approved for newly diagnosed glioblastoma in October 2015; ongoing trials for broader applications |used_for=Newly diagnosed glioblastoma, with trials for other cancers ongoing |clinical_trial_phase=Phase 3 (EF-14 Trial); Phase 3 TRIDENT trial ongoing |common_side_effects=Mild to moderate skin irritation beneath transducer arrays, thrombocytopenia, nausea, constipation, vomiting, fatigue, he..."
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Optune"